Search results

  1. forestglip

    MRC/NIHR DecodeME Showcase meeting online and in person Nov 6th

    What is even the reason for limiting virtual attendees?
  2. forestglip

    Autoantibodies against type I interferons are a prominent feature in SARS-CoV-2 fatal disease and hospitalization, 2025, Netto et al

    Autoantibodies against type I interferons are a prominent feature in SARS-CoV-2 fatal disease and hospitalization Rebeca Linhares Abreu Netto, Catherine Chen, Victor Irungu Mwangi, Carlos Eduardo Padron de Morais, Mariana Simão Xavier, Luiz Gustavo Gardinassi, Emily Marie Eriksson, Nicholas...
  3. forestglip

    Symptom-based clusters in people with ME/CFS: an illustration of clinical variety in a cross-sectional cohort 2023,Vaes,Jason et al

    New preprint with further analysis of this data (link to thread): Analysis of Potential Subgroups in Vaes ME/CFS Patient Clusters, 2025, Squires
  4. forestglip

    Preprint Analysis of Potential Subgroups in Vaes ME/CFS Patient Clusters, 2025, Squires

    Refers to this study (link to thread): Symptom-based clusters in people with ME/CFS: an illustration of clinical variety in a cross-sectional cohort 2023,Vaes,Jason et al
  5. forestglip

    Preprint Analysis of Potential Subgroups in Vaes ME/CFS Patient Clusters, 2025, Squires

    Analysis of Potential Subgroups in Vaes ME/CFS Patient Clusters Erik Squires Background: Vaes et al. (2023)[@vaes2023] identified 13 symptom clusters in a large cohort of ME/CFS patients. Symptom intensity is broadly correlated with post-exertional malaise (PEM) severity, with variation across...
  6. forestglip

    Maeve Boothby O'Neill - articles about her life, death and inquest

    A post about the NICE Clinical Knowledge Summary was moved to: NICE Clinical Knowledge Summary (CKS) on ME/CFS, July 2025
  7. forestglip

    Preprint Soluble IL-2R impairs muscle cell mitochondrial respiration in fatigued individuals with post-acute sequelae of COVID-19, 2024, Peterson Brown

    Old papers, so maybe no PEM in some cases, but doesn't look like any striking differences: Dysregulated Expression of Soluble Immune Mediator Receptors in a Subset of Patients with Chronic Fatigue Syndrome: Cross-Sectional Categorization of Patients by Immune Status, 1995 Dysregulated...
  8. forestglip

    Preprint Soluble IL-2R impairs muscle cell mitochondrial respiration in fatigued individuals with post-acute sequelae of COVID-19, 2024, Peterson Brown

    No significant difference, but it looks like the measurement was between different ME/CFS subgroups (infectious onset or not, or having certain genetic alleles), and not compared to healthy controls.
  9. forestglip

    Post-acute non-specific symptoms following COVID-19 vaccination: a Danish population-based study, 2025, Jensen et al

    Yeah I just think there may or may not be certain subjective and objective measures that can be influenced by expectations. I certainly think it's unlikely that all objective outcomes could be influenced by expectations. If a patient got a placebo and was told it was a drug designed to...
  10. forestglip

    Post-acute non-specific symptoms following COVID-19 vaccination: a Danish population-based study, 2025, Jensen et al

    Maybe we're working with different ideas of what placebo means. I would consider if someone swore that they felt feverish after taking no medication, even if a thermometer does not indicate any higher temperature, would be a placebo effect. The effect would just be on the subjective feeling of...
  11. forestglip

    Post-acute non-specific symptoms following COVID-19 vaccination: a Danish population-based study, 2025, Jensen et al

    Well they did mention one of the two, but I agree, excluding the other suggests like they might prefer these explanations. Unlike nocebus from a parallel universe which has no existing evidence or reason for believing in, a placebo effect is biologically plausible. Thoughts can make my heart...
  12. forestglip

    Preprint Soluble IL-2R impairs muscle cell mitochondrial respiration in fatigued individuals with post-acute sequelae of COVID-19, 2024, Peterson Brown

    I'm not sure how exactly this relates to the thread's study, but the same team published a letter to the editor. I haven't read either in detail, but it looks like the same data is used for the main sIL2R finding in both. Soluble IL-2R: A potential therapeutic target for mitochondrial...
  13. forestglip

    Post-acute non-specific symptoms following COVID-19 vaccination: a Danish population-based study, 2025, Jensen et al

    So is invoking reporting bias, no? Or suggesting that they had more adverse effects for a legitimate health reason? Based on what definition? Wikipedia says "A nocebo effect is said to occur when a patient's expectations for a treatment cause the treatment to have a worse effect than it...
  14. forestglip

    Post-acute non-specific symptoms following COVID-19 vaccination: a Danish population-based study, 2025, Jensen et al

    Why is nocebo effect questionable as a potential explanation? They both seem fine to me as speculation, but I agree, they should have also included a third option of vaccine-concerned people having a reason to be concerned about their own bodies.
  15. forestglip

    Preprint Initial findings from the DecodeME genome-wide association study of myalgic encephalomyelitis/chronic fatigue syndrome, 2025, DecodeMe Collaboration

    Oh that's great. Good to see another person got neurons/excitatory neurons in the cell type enrichment analysis.
  16. forestglip

    Who will pursue treatments for low NK cell patients?

    Pulling out some quotes about the difference from a quick scan:
  17. forestglip

    Preprint Initial findings from the DecodeME genome-wide association study of myalgic encephalomyelitis/chronic fatigue syndrome, 2025, DecodeMe Collaboration

    I'm just concerned that there's no other way to read the sentence when it uses "and" than that it's suggesting they are all involved: Maybe "or" instead?
  18. forestglip

    Preprint Initial findings from the DecodeME genome-wide association study of myalgic encephalomyelitis/chronic fatigue syndrome, 2025, DecodeMe Collaboration

    Thanks for the blog! I think fine mapping refers to identifying the causal variant out of all the significant variants, not identifying the gene that the variant affects. I think that would be 'gene prioritization': - https://royalsocietypublishing.org/doi/10.1098/rsob.190221 --- I don't...
  19. forestglip

    Post-acute non-specific symptoms following COVID-19 vaccination: a Danish population-based study, 2025, Jensen et al

    Post-acute non-specific symptoms following COVID-19 vaccination: a Danish population-based study Christina Bisgaard Jensen, Kristoffer Torp Hansen, Bodil Hammer Bech, Stefan Nygaard Hansen, Henrik Nielsen, Charlotte Ulrikka Rask, Per Fink, Thomas Meinertz Dantoft, Torben Jørgensen, Jeremy A...
  20. forestglip

    Review Targeting Symptoms of Fibromyalgia Through Transcutaneous Electrical Nerve Stimulation (TENS): A Systematic Review of [Reviews], 2025, Sahebari et al

    Targeting Symptoms of Fibromyalgia Through Transcutaneous Electrical Nerve Stimulation (TENS): A Systematic Review of Current Systematic Reviews Masoud Sahebari, MD, Fateme Tahmasbi, MD, Alireza Rahimi-Mamaghani, MD, MSc, FIPP [Line breaks added] Background Fibromyalgia syndrome (FMS) is a...
Back
Top Bottom